Fatty Acids Activate the Transcriptional Coactivator YAP1 to Promote Liver Fibrosis via p38 Mitogen-Activated Protein Kinase-Reference-Cited by-同舟云学术

Fatty Acids Activate the Transcriptional Coactivator YAP1 to Promote Liver Fibrosis via p38 Mitogen-Activated Protein Kinase

Published:2021 Issue:4 Volume:12 Page:1297-1310
ISSN:2352-345X
Container-title:Cellular and Molecular Gastroenterology and Hepatology
language:en
Short-container-title:Cellular and Molecular Gastroenterology and Hepatology

Author:

Salloum Shadi,Jeyarajan Andre J.,Kruger Annie J.,Holmes Jacinta A.,Shao Tuo,Sojoodi Mozhdeh,Kim Myung-Ho,Zhuo Zhu,Shroff Stuti G.,Kassa Andrew,Corey Kathleen E.,Khan Sanjoy K.,Lin Wenyu,Alatrakchi Nadia,Schaefer Esperance A.K.,Chung Raymond T.

Funder

NIH

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference30 articles.

1. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study;Williams;Gastroenterology,2011

2. Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis;Diehl;N Engl J Med,2017

3. OPTN/SRTR 2017 Annual Data Report: liver;Kim;Am J Transplant,2019

4. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease;Estes;Hepatology,2018

5. Accumulation of duct cells with activated YAP parallels fibrosis progression in non-alcoholic fatty liver disease;Machado;J Hepatol,2015

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progranulin: A promising biomarker and therapeutic target for fibrotic diseases;Acta Pharmaceutica Sinica B;2024-08

2. YAP mediates HIV-related liver fibrosis;JHEP Reports;2024-07

3. Expression of transforming growth factor β signalling molecules and their correlations with genes in loci linked to polycystic ovary syndrome in human foetal and adult tissues;Reproduction, Fertility and Development;2024-06-17

4. Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression;Archives of Pharmacal Research;2024-06

5. The qualitative and quantitative analysis of Ganoderma lucidum spore powder chemical compounds as p38 MAPK inhibitors by the generation and verification of pharmacophore modelling;LWT;2024-02